• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 119.00(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7690.0
  • ISIN : INE858L01010
30.00 0 (0.17%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    30.00

  • Today’s High

    30.98

  • Open

    30.98

  • Perv Close

    29.95

  • 52W Low

    26.10

  • 52W High

    44.96

Key Indicators

  • P/E(TTM)

    100.00

  • Mar.Cap (₹Cr.)

    30.00

  • Div & Yield %

    0.00

  • Book Value(₹)

    34.11

  • Debt-Equity Ratio

    0.17

  • AGM Date

    17-Jun-2025

  • EPS

    0.30

  • P/E Ratio

    100.00

Financials Ratios

  • Debt-Equity Ratio

    0.53

  • Mar.Cap (₹Cr.)

    30.00

  • RONW (%)

    1.43

  • ROCE (%)

    4.76

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    34.10

  • Sales( ₹ in Cr.)

    36.93

  • NP (in Cr.)

    0.30

  • NP Var(%)

    -29.0

  • Div%

    0.0

  • CPS (₹)

    1.70

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    29.95

  • 52 Week High

    44.96

  • 52 Week Low

    26.10

  • Price BSE

    30.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    29.95

  • P/C Ratio

    17.50

  • P/E Ratio

    101.50

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 43.26 51.31 58.96 51.36 51.34 48.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.26 51.31 58.96 51.36 51.34 48.08
Other Income 0.01 0.01 0.10 3.86 0.12 0.09
Stock Adjustments 0.40 -0.52 2.31 -1.69 -0.52 -0.46
Total Income 43.67 50.80 61.37 53.53 50.94 47.71
EXPENDITURE :            
Raw Materials 33.71 40.36 44.41 41.28 42.06 39.14
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.77 0.78
Employee Cost 3.87 3.55 4.14 3.47 3.27 2.29
Other Manufacturing Expenses 0.39 0.44 0.43 0.60 0.40 0.41
Selling and Administration Expenses 1.81 2.05 1.52 1.03 0.95 0.77
Miscellaneous Expenses 0.21 0.06 5.19 0.07 0.04 0.58
Employee Benefit Expenses 3.87 3.55 4.14 3.47 3.27 2.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 39.99 46.46 55.67 46.45 47.48 43.96
Operating Profit 3.69 4.35 5.69 7.08 3.46 3.74
Interest 1.59 1.62 1.68 1.42 1.54 1.59
Gross Profit 2.10 2.73 4.01 5.66 1.92 2.15
Depreciation 1.54 1.60 1.76 1.37 1.46 1.71
Profit Before Tax 0.56 1.13 2.25 4.29 0.46 0.44
Current Tax 0.20 0.35 0.67 0.47 0.12 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 -0.11 -0.02 0.54 0.01 -0.08
Reported Net Profit 0.42 0.89 1.59 3.28 0.33 0.41
Extraordinary Items 0.00 0.00 0.00 2.88 0.00 0.00
Adjusted Net Profit 0.42 0.89 1.59 0.40 0.33 0.41
Adjustment below Net Profit 0.00 0.00 0.01 0.00 0.00 0.00
P & L Balance brought forward 14.40 13.51 11.91 8.63 8.30 7.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.82 14.40 13.51 11.91 8.63 8.30
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Earnings Per Share(Adj)-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Book Value 33.82 33.43 32.44 30.61 26.86 29.45
Book Value(Adj)-Unit Curr 33.82 33.43 32.44 30.61 26.86 29.45

Shareholding Pattern

  • Promoter Group

    54.39%

  • Public Share Holding

    45.61%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,439,204 54.39 5,439,204 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,439,204 54.39 5,439,204 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 7,584 0.08 7,584 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 220,152 2.20 220,152 34
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,582,606 15.83 1,582,606 19
Individuals holding nominal share capital up to Rs. 1 lakh 2,750,454 27.50 2,159,054 5,189
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,560,796 45.61 3,969,396 5,249
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,000 100.00 9,408,600 5,252

Company Background

Concord Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Drugs Ltd
  • BSE Code : 7690.0
  • ISIN : INE858L01010

  • Incorporation Year

    1995

  • Registered Office

    Survey No 249 Brahmanapally V
    Hayathnagar M, Ranga Reddy,
    Telangana-501511

  • Telephone

    91-40-24036379

  • FAX

  • Chairman

    S Nagi Reddy

  • Managing Director

    S Nagi Reddy

  • Company Secretary

    Namratha Nagla

  • Auditor

    Pundarikashyam and Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Concord Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Drugs 30.00 43.27 43.26 100.00 4.25
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92